Skip to content

Clinical trials

Conjunctivitis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Conjunctivitis Country / region: United States Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20044
20072
20081
20091
20101
20112
20122
20132
20151
20161
20201
20214
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)3
Merck Sharp & Dohme LLC2
NovaBay Pharmaceuticals, Inc.2
Rapid Pathogen Screening2
Regeneron Pharmaceuticals2
Alcon Research1
Bausch & Lomb Incorporated1
Baxis Pharmaceuticals, Inc.1
Circassia Limited1
Invirsa, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Conjunctivitis26
Conjunctivitis, Allergic4
Conjunctivitis, Bacterial4
Eye Infections4
Conjunctivitis, Viral3
Keratitis3
Adenoviridae Infections2
Corneal Diseases2
Hypersensitivity2
Keratoconjunctivitis2

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.